Y-90 Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival

Xing Minzhi; Lahti Steven; Kokabi Nima; Schuster David M.; Camacho Juan C.; Kim Hyun S.

首页> 外文期刊>Clinical nuclear medicine >Y-90 Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival

【24h】

Y-90 Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival

机译：Y-90放射性栓塞肺分流在原发性和转移性肝癌中作为生存的生物标志物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective The aim of this study was to investigate pre-Y-90 lung shunt fraction (LSF) as a prognostic factor for overall survival (OS) in Y-90 (resin/glass) planning Tc-99m-MAA hepatopulmonary shunt studies for primary (hepatocellular carcinoma [HCC], intrahepatic cholangiocarcinoma) and metastatic liver tumors.

机译：目的这项研究的目的是调查Y-90之前的肺分流分数（LSF）作为Y-90（树脂/玻璃）总体生存时间（OS）的预后因素，并计划将Tc-99m-MAA肝肺分流研究用于原发性（肝细胞癌[HCC]，肝内胆管癌）和转移性肝肿瘤。

著录项

来源
《Clinical nuclear medicine》 |2016年第1期|共7页
作者
Xing Minzhi; Lahti Steven; Kokabi Nima; Schuster David M.; Camacho Juan C.; Kim Hyun S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
Y-90 radioembolization; colorectal liver metastases; hepatocellular carcinoma; hepatopulmonary shunt fraction; intrahepatic cholangiocarcinoma; melanoma liver metastases; neuroendocrine tumor liver metastases;

机译：Y-90放射栓塞;大肠肝转移;肝细胞癌;肝肺分流分数;肝内胆管癌;黑素瘤肝转移;神经内分泌肿瘤肝转移;

相似文献

外文文献
中文文献
专利

1. Y-90 Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival [J] . Xing Minzhi, Lahti Steven, Kokabi Nima, Clinical nuclear medicine . 2016,第1期

机译：Y-90放射性栓塞肺分流在原发性和转移性肝癌中作为生存的生物标志物
2. Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based Y-90 Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the Liver [J] . Edalat Faramarz, Camacho Juan C., Kokabi Nima, Clinical nuclear medicine . 2016,第2期

机译：标准化的新增代谢活性可预测在无法切除的化学难治性转移性大肠直肠癌的动脉内树脂基Y-90放射栓塞治疗后的生存率。
3. Early post-treatment FDG PET predicts survival after Y-90 microsphere radioembolization in liver-dominant metastatic colorectal cancer [J] . Sabet Amir, Meyer Carsten, Aouf Anas, European Journal of Nuclear Medicine and Molecular Imaging . 2015,第3期

机译：早期治疗后FDG PET预测Y-90微球放射性栓塞后以肝为主的转移性大肠癌的存活率
4. Liver-Directed Therapies for Primary and Metastatic Disease: Radioembolization and Chemoembolization [C] . Daniel Y. Sze Gastrointestinal Cancers Symposium . 2014

机译：肝脏定向治疗原发性和转移性疾病：放射性栓塞和化疗栓塞
5. Development of dose response to Y-90 microsphere treatment of metastatic liver cancer by quantitative analysis of SPECT and PET images . [D] . Campbell, Janice M. 2008

机译：通过SPECT和PET图像定量分析建立Y-90微球治疗转移性肝癌的剂量反应。
6. Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio [O] . Seza A Gulec, Geraldine Mesoloras, William A Dezarn, 2007

机译：Y-90微球治疗原发性和转移性肝癌患者的安全性和有效性：治疗的肿瘤选择性与肿瘤肝流量的关系
7. Clinical Outcomes Of Patients With Primary Or Metastatic Liver Tumors Treated With Dose-Escalated Yttrium-90 (Y-90) Transarterial Radioembolization (TARE) [O] . A. Bommireddy, R.I. Chin, C. Malone, 2020

机译：用剂量升级的钇-90（Y-90）rantarterial放射性栓塞（皮重）治疗原发性或转移性肝肿瘤患者的临床结果

Y-90 Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅